UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030775 |
|---|---|
| Receipt number | R000035140 |
| Scientific Title | Interview to medical doctors on the information site of integrative medicine (eJIM) |
| Date of disclosure of the study information | 2018/01/12 |
| Last modified on | 2020/07/14 09:39:28 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Interview to medical doctors on the information site of integrative medicine (eJIM)
Acronym
Interview to doctors on eJIM
Scientific Title
Interview to medical doctors on the information site of integrative medicine (eJIM)
Scientific Title:Acronym
Interview to doctors on eJIM
Region
| Japan |
Condition
Condition
Not applicable
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the usability of the information site on integrative medicine (eJIM) from the viewpoint of medical doctor
Basic objectives2
Others
Basic objectives -Others
To evaluate the usefulness of the information site on integrative medicine (eJIM) from the viewpoint of medical doctor
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Usability
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Medical doctors working for Kanazawa Medical University
2) Those whom written informed consent can be obtained from
3) 3 doctors younger than 40 years old, 3 doctors older than 39 years old
4) 3males and 3 females
5) 6 from different department/specialty
6) 2 positive, 2 intermediate, and 2 negative attitude towards integrative medicine
Key exclusion criteria
1) Those whom written informed consent cannot be obtained from
Target sample size
6
Research contact person
Name of lead principal investigator
| 1st name | Yoshiharu |
| Middle name | |
| Last name | Motoo |
Organization
Kanazawa Medical Unversity
Division name
Department of Medical Oncology
Zip code
920-0293
Address
1-1 Daigaku, Uchinada, Ishikawa 920-0293
TEL
076-286-2211
motoo@kanazawa-med.ac.jp
Public contact
Name of contact person
| 1st name | Kazuho |
| Middle name | |
| Last name | Hisamura |
Organization
Kanazawa Medical Unversity
Division name
Department of Medical Oncology
Zip code
920-0293
Address
1-1 Daigaku, Uchinada, Ishikawa 920-0293
TEL
076-286-2211
Homepage URL
hisamura@kanazawa-med.ac.jp
Sponsor or person
Institute
Kanazawa Medical University
Institute
Department
Personal name
Funding Source
Organization
Japan Agency for Medical Research and Development
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board
Address
1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan
Tel
076-286-2211
tiken@kanazawa-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 01 | Month | 12 | Day |
Related information
URL releasing protocol
https://www.sciencedirect.com/science/article/pii/S221342202030086X?via%3Dihub
Publication of results
Published
Result
URL related to results and publications
https://www.sciencedirect.com/science/article/pii/S221342202030086X?via%3Dihub
Number of participants that the trial has enrolled
231
Results
231 physicians responded to the internet survey. 35% of the physicians used or advised on TCIM in clinical practice. Kampo medicines (87.8%) and dietary supplements (24.7%) were common. Most physicians were not aware of which TCIM their patients used.
Results date posted
| 2020 | Year | 07 | Month | 14 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Japanese physicians
Participant flow
Monitor physicians responded to e-mail notice.
Adverse events
None
Outcome measures
Use of TCIM
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 01 | Month | 06 | Day |
Date of IRB
| 2017 | Year | 12 | Month | 16 | Day |
Anticipated trial start date
| 2018 | Year | 01 | Month | 25 | Day |
Last follow-up date
| 2018 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Participants are asked questions while browsing the eJIM website.
Management information
Registered date
| 2018 | Year | 01 | Month | 11 | Day |
Last modified on
| 2020 | Year | 07 | Month | 14 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035140
